Mount Sinai Health System Recognized by Fortune as One of “America’s Most Innovative Companies 2023”
Mount Sinai Health System has been named one of “America’s Most Innovative Companies 2023” by Fortune magazine in its inaugural list. Mount Sinai was recognized in the Healthcare and Social category.
Fortune’s list of America’s Most Innovative Companies is based on a holistic view of a company’s innovative activity. The companies were identified based on product innovation, process innovation, and innovation culture. Fortune partnered with Statista, an online platform specializing in market and consumer data, to deploy online surveys. Statista evaluated the companies across the country by internally viewing the process innovation and product innovation and surveying experts in various fields. Statista also collaborated with LexisNexis PatentSight to use their platform to analyze the quantity and value of a company’s patents.
The Mount Sinai Health System continues to innovate in all facets of medicine, including research and clinical trials, medical tools and technology, patient care, and more. In the past year Mount Sinai has, among other things, assisted in the development of a groundbreaking heart disease medication known as the polypill, revealed a new immunotherapy for multiple myeloma patients, identified a new gene that drives colon cancer, and identified the role of an Alzheimer’s disease risk gene in the brain.
“We are honored to receive this recognition from Fortune,” said Kenneth L. Davis, MD, Chief Executive Officer of Mount Sinai Health System. “This acknowledges Mount Sinai as a pillar in health care innovation. We find new ways to advance medicine, pushing the boundaries of science and medicine, with the overarching goal to improve health of patients everywhere.”
The America’s Most Innovative Companies list reinforces that Mount Sinai has an outstanding innovation culture and continues to modernize medicine for the future. The list honors 300 U.S.-based companies that have proved to be at the forefront of innovation in different sectors.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm Beach
May 15, 2023 View All Press Releases
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
Oct 31, 2022 View All Press Releases
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
Oct 18, 2022 View All Press Releases